MDMA Therapy News — MDMA-Assisted Therapy News & Research
In focus
Building Accountable MDMA Research: A Trauma-Care Safeguards Framework
MDMA Therapy News Editorial Team · October 30, 2026
Read story1 / 2
News & insights
Insight
When a Boundary Concern Is Reported: Accountability in MDMA Research
By MDMA Therapy News Editorial Team · October 30, 2026
News
From Inquiry to Randomization: Reading a Trial Screening Flowchart
By MDMA Therapy News Editorial Team
News
Who Gets Into the Evidence? Recruitment Barriers in MDMA PTSD Research
By MDMA Therapy News Editorial Team
News
Beyond a Lower PTSD Score: What Functional Outcomes Actually Measure
By MDMA Therapy News Editorial Team
News
Building Accountable MDMA Research: A Trauma-Care Safeguards Framework
By MDMA Therapy News Editorial Team
News
How to Audit a PTSD Trial Claim: An MDMA Evidence Workbook
By MDMA Therapy News Editorial Team
News
Informed Consent for MDMA Research: More Than a Signature
By MDMA Therapy News Editorial Team
Editor's picks
Selected story
Building Accountable MDMA Research: A Trauma-Care Safeguards Framework
October 30, 2026
Selected story
How to Audit a PTSD Trial Claim: An MDMA Evidence Workbook
October 30, 2026
Selected story
Informed Consent for MDMA Research: More Than a Signature
October 29, 2026
Selected story
Therapist Boundaries in MDMA Research: Questions Patients Can Ask
October 29, 2026
Latest headlines
The big picture
Reaching PTSD Care: What Telehealth Trials Can—and Cannot—Teach MDMA Research
October 30, 2026
Read the full storyLatest News
Reaching PTSD Care: What Telehealth Trials Can—and Cannot—Teach MDMA Research
October 30, 2026
Keeping PTSD Care Moving While MDMA Remains Investigational
October 30, 2026
Designing a Durability Test: Relapse, Follow-Up, and Intervening Care
October 30, 2026
Choosing a Comparator for MDMA Trials: Why No Control Is Perfect
October 30, 2026
When a Boundary Concern Is Reported: Accountability in MDMA Research
October 30, 2026
From Inquiry to Randomization: Reading a Trial Screening Flowchart
October 30, 2026
Who Gets Into the Evidence? Recruitment Barriers in MDMA PTSD Research
October 30, 2026
Beyond a Lower PTSD Score: What Functional Outcomes Actually Measure
October 30, 2026
Informed Consent for MDMA Research: More Than a Signature
October 29, 2026
Therapist Boundaries in MDMA Research: Questions Patients Can Ask
October 29, 2026
MDMA Integration: What Support Can Offer and What Remains Unproven
October 29, 2026
Considering an MDMA Trial? Understand Placebos Before Enrolling
October 29, 2026
Does Improvement Last? Reading MDMA Long-Term Follow-Up Carefully
October 29, 2026
MDMA and Couples Therapy: What a Six-Couple Pilot Can Tell Us
October 29, 2026
MDMA for Social Anxiety in Autistic Adults: Revisiting the Small Pilot
October 29, 2026
Expectancy in MDMA Research Starts Before the First Appointment
October 29, 2026
MDMA Safety Data: Why Adverse-Event Reporting Matters
October 29, 2026
MDMA Brain Mechanisms Are Not the Same as Clinical Proof
October 29, 2026
What MDMA-Assisted Therapy Actually Is — and What It Isn't
October 29, 2026
Inside an MDMA-Assisted Therapy Session: Preparation, the Dosing Day, Integration
October 28, 2026
Who Should Not Get MDMA-Assisted Therapy: Heart Risks, Drug Interactions and Screening
October 27, 2026
Where MDMA Therapy Is Legal in 2026 — and What Access Actually Costs
October 26, 2026